Navigation Links
New therapy found for rare lung disorder
Date:3/16/2011

ated with improvement in measures of functional performance and quality of life.

Sirolimus also reduced levels of serum vascular endothelial growth factor-D, or VEGF-D, a protein that is known to be elevated in LAM. VEGF-D promotes the growth of lymphatic vessels and can be involved in the spread of cancers.

"After discontinuation of sirolimus, lung function decline resumed and paralleled the placebo group," McCormack says. "Adverse events were more common with sirolimus, but the frequency of serious adverse events between the groups was not different."

McCormack says that these results suggest that sirolimus may be useful as therapy for moderately severe LAM-related lung disease.

"LAM is typically slowly progressive, and sirolimus therapy has risks, so treatment decisions should be individualized. Care must be taken in generalizing the results to those with milder or more severe lung disease due to LAM," he says. "Also, additional trials are needed to determine the optimal dose and duration of treatment with sirolimus. Given the toxicity profile of the drug during a one-year period, the long-term safety of this approach over an extended course must be carefully evaluated."

The trial involved efforts by the LAM Foundation that lobbied for the NIH's attention, organized and recruited patients and supported pivotal basic and clinical research that formed the scientific basis for the study.


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Sirolimus therapy alleviates symptoms of lung disease LAM
2. Research study explores gene therapy treatment to reduce symptoms of Parkinsons disease
3. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
4. Ohio State study: Targeted ovarian cancer therapy not cost-effective
5. Stroke patients benefit from family involvement in exercise therapy
6. Extra Tests Not a Deterrent to Experimental Cancer Therapy
7. Gene Therapy Against HIV Not a Proven Cure, Experts Say
8. WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
9. BUSM study shows chemoradiotherapy prior to surgery improves survival
10. Fish oil fights weight loss due to chemotherapy
11. Lack of health insurance limits hepatitis C patients access to latest antiviral therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... AZ (PRWEB) , ... September 05, 2015 , ... ... Artists from China for an exclusive, one-night exhibition of their work at Paradise Valley ... exhibit on Friday, September 18, from 6-9 pm. The artists will be on hand ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article ... being cared for in nursing homes and assisted living facilities are receiving insufficient care ... story in which her father was at one point close to death, not because ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... According ... has been developed that changes color when subjected to an impact force that is ... could be implemented in helmets or other sporting equipment so that coaches or officials ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an ... of the American Dental Association presented data showing that it is safe for pregnant ... of pregnant women that had undergone local anesthesia with a group that hadn’t, researchers ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Insight Product Development has effectively doubled the size of its annual health tech ... medical device and digital health startups to compete for cash and prizes to ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3
... Nov. 10 ChromaDex (OTC,Bulletin Board: CDXC), today ... with Cargill (Wayzata, Minn.) to supply global,analytical reference ... of stevia. This provides the ability for food ... consumer products., With the introduction of Truvia(TM) ...
... SAN DIEGO, Nov. 10 Favrille, Inc. ... a pure-play,health information company focused on secure ... announced today the signing of a,definitive merger ... on,continuing to build and develop the MyMedicalRecords.com ...
... SAN DIEGO, Nov. 10 After two ... medicine, mind-body physiology,nutrition, and holistic clinical care, ... of credentials the completion of a prestigious ... Launched in 2000 by,internationally-recognized integrative medicine pioneer ...
... Nov. 10 Dr. James Cook, president of,the American ... holiday tradition -- treating pets that have become sick ... into New Years, we,ll see it,every year at my ... Cook explains. "People want to involve their pets in ...
... project coupled with phenomenal growth in large-scale applications such as combinatorial ... highly specialized laboratory equipment. Global Pipettes and Pipettors market is projected ... ... Jose, CA (PRWEB) November 10, 2008 -- Pipettes and pipettors are ...
... rise in the number of laboratories, and lab ... is projected to reach $84.9 million by the ... America hold strong potential for future growth, given ... instruments in these markets. Quality, durability, efficiency, and ...
Cached Medicine News:Health News:ChromaDex Partners With Cargill to Provide Global Quality Control Methods and Standards for Sweet Components of Stevia 2Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 2Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 3Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 4Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 5Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 6Health News:Andrew Weil's Integrative Medicine Program Bestows Honors on Chopra Center's Director of Women's Health: Valencia Porter, M.D. receives Integrative Medicine Fellowship 2Health News:AVMA's Top Ten List on Holiday Pet Health 2Health News:Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts 2Health News:World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts 3
(Date:9/4/2015)... Physician E-sampling is becoming well established across ... key marketing sales tactic in recent years. However, some ... a supplement to traditional sampling. According ... E-sampling has been seeded across multiple therapeutic areas- including ... has been in place for five or more years ...
(Date:9/4/2015)... 2015  Janssen Research & Development, LLC (Janssen) ... (FDA) has accepted for Priority Review the Biologics ... for patients with multiple myeloma who are refractory ... immunomodulatory agent (IMiD), or who have received three ... PI and an IMiD. This is referred to ...
(Date:9/4/2015)... , Sept. 4, 2015 Fair Rate Funding, ... Jersey , reports a dramatic increase in lawsuit filings ... of filed Xarelto lawsuits in the Philadelphia ... to over 300 cases.  In the Louisiana ... for the Eastern District of Louisiana , ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... Safety and Pharmacokinetic Results in Healthy Volunteers to be Presented at ... ... (Nasdaq: ANDS ) announced today preliminary results of a Phase I,clinical trial ... trial of ANA598 in patients chronically infected,with hepatitis C virus (HCV). In the ...
... Rehovot, Israel, reported today results of its internal,clinical trial of ... cancer., In the trial a total of 76 sputum ... Healthy individuals that never smoked 2. Heavy smokers with ... cancer patients (Stage 1) 4. Advanced stage lung cancer ...
Cached Medicine Technology:Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 2Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 3Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 4Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 5Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 6BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: